Chemotherapy of gastrointestinal cancer.
D001500:BCG Vaccine; D001761:Bleomycin / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005467:Floxuridine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007167:Immunotherapy; D008130:Lomustine / Q000627:therapeutic use; D008558:Melphalan / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D009163:Mycobacterium bovis; D011070:Poly I-C / Q000627:therapeutic use; D011160:Porfiromycin / Q000627:therapeutic use; D013311:Streptozocin / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D013994:Tilorone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D001500:BCG Vaccine; D008937:Mitomycins; D005467:Floxuridine; D003561:Cytarabine; D001761:Bleomycin; D002699:Chlorambucil; D014750:Vincristine; D013311:Streptozocin; D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D013852:Thiotepa; D011160:Porfiromycin; D003981:Diazoxide; D013994:Tilorone; D011070:Poly I-C; D008558:Melphalan; D005472:Fluorouracil; D002330:Carmustine; D008727:Methotrexate